outcomeCategory,disease,model,comparison,database,nTNF,nComparator,HazardRatio,RobustWaldLower,RobustWaldUpper,indValidHR,indSigHR
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1083,420,7124.1037326,1000.8963646,50707.40167,0,0
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4790,1790,0.2901046573,0.1207188557,0.6971629388,1,1
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4845,4180,0.6984293901,0.4730545478,1.0311783604,1,0
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1083,1901,0.1474562015,0.0190529979,1.1412026327,1,0
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4790,7884,0.3567802314,0.1785092863,0.7130840984,1,1
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4845,17740,0.5363802629,0.3984227134,0.7221068899,1,1
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs DMARD,MPCD,1083,420,26185.82307,3685.2933207,186063.16247,0,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4790,1790,0.3960209803,0.1421591349,1.1032187063,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs DMARD,Medicare,4845,4180,0.8847572468,0.5636760463,1.3887327498,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1083,1901,0.5572137415,0.072209374,4.2998178306,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4790,7884,0.4939176147,0.2084816685,1.1701489724,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4845,17740,0.6726057545,0.4654180992,0.9720260165,1,1
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1083,420,26012.803351,3677.9150539,183980.85009,0,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4790,1790,0.3962582481,0.1426542427,1.1007075302,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4845,4180,0.9038771333,0.5863870266,1.3932673049,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1083,1901,0.5591651361,0.0723067004,4.3241587277,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4790,7884,0.4951702869,0.2087592345,1.1745282245,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4845,17740,0.6723243965,0.4602604623,0.9820962936,1,1
Cancer,Hematologic Cancer,"c Weighted, covariates (age)",TNF vs DMARD,MPCD,1083,420,71302.385436,10151.834595,500799.15323,0,0
Cancer,Hematologic Cancer,"c Weighted, covariates (age)",TNF vs DMARD,Marketscan,4790,1790,0.3735626646,0.1345570005,1.0370999941,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (age)",TNF vs DMARD,Medicare,4845,4180,0.8331776113,0.533933745,1.3001330943,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,MPCD,1083,1901,0.6343463602,0.0817028241,4.9251088819,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Marketscan,4790,7884,0.5155665349,0.2166077837,1.2271435837,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Medicare,4845,17740,0.7090778131,0.4886715365,1.0288942725,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,MPCD,1083,420,70339.557633,10054.594185,492078.87231,0,0
Cancer,Hematologic Cancer,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Marketscan,4790,1790,0.3739838423,0.1349911486,1.0360969277,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Medicare,4845,4180,0.851559289,0.5546466381,1.3074147987,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,MPCD,1083,1901,0.6334739217,0.0813838311,4.930822304,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Marketscan,4790,7884,0.5175635354,0.2171748487,1.2334393912,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Medicare,4845,17740,0.7099049716,0.4834825753,1.0423644914,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1083,421,1.5989226033,0.4666773798,5.4782031491,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4795,1796,0.8089680201,0.4851269202,1.3489856577,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4864,4229,0.8661695819,0.7073659472,1.060624628,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1083,1901,1.1153841618,0.5900257879,2.1085211087,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4795,7897,0.9322701757,0.6580425056,1.3207774165,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4864,17850,0.6839272554,0.5929218008,0.788900813,1,1
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs DMARD,MPCD,1083,421,1.956805966,0.544573079,7.0313604114,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4795,1796,1.1308668789,0.6586459099,1.9416501015,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs DMARD,Medicare,4864,4229,1.2900469416,1.0313722411,1.6135988978,1,1
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1083,1901,1.5065803361,0.7396938534,3.0685455861,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4795,7897,1.2228720041,0.8302781701,1.8011023202,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4864,17850,1.0119611101,0.8539881723,1.1991562899,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1083,421,2.0777466592,0.5790900679,7.4548527411,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4795,1796,1.1964381651,0.6961779124,2.0561759538,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4864,4229,1.3562582028,1.0897389436,1.6879605188,1,1
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1083,1901,1.4781771865,0.7254187415,3.0120641635,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4795,7897,1.2030616808,0.8161707446,1.7733512472,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4864,17850,0.9952389593,0.8375515631,1.182614456,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (age)",TNF vs DMARD,MPCD,1083,421,1.6287153193,0.4474895684,5.9279897873,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (age)",TNF vs DMARD,Marketscan,4795,1796,1.0330198907,0.6000385537,1.7784358823,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (age)",TNF vs DMARD,Medicare,4864,4229,1.2169379618,0.9745495155,1.519612887,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,MPCD,1083,1901,1.8647044797,0.9037279248,3.8475327597,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Marketscan,4795,7897,1.308374284,0.8843183112,1.9357772484,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Medicare,4864,17850,1.0849515415,0.9126208566,1.2898235217,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,MPCD,1083,421,1.7168845773,0.4726694499,6.2362664904,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Marketscan,4795,1796,1.0785693326,0.6260797196,1.8580889444,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Medicare,4864,4229,1.272128049,1.0247414883,1.5792370968,1,1
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,MPCD,1083,1901,1.8157275424,0.8796596969,3.7478885529,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Marketscan,4795,7897,1.2909691234,0.8723516478,1.9104695701,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Medicare,4864,17850,1.0672036241,0.8949408994,1.2726243444,1,0
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1074,417,1.0428866048,0.419740977,2.5911515199,1,0
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4740,1751,0.5391297972,0.3772583213,0.7704560027,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4647,3983,0.7822375077,0.6612528942,0.9253577925,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1074,1880,0.4187324761,0.2559650366,0.6850032678,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4740,7794,0.4844952464,0.3797674091,0.618103708,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4647,17285,0.4752164219,0.4200793205,0.5375904897,1,1
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs DMARD,MPCD,1074,417,1.7539637537,0.6755331952,4.5540158072,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4740,1751,0.8576441558,0.5824174464,1.2629317725,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs DMARD,Medicare,4647,3983,1.2346024548,1.0180369788,1.4972375789,1,1
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1074,1880,0.6345355064,0.3623925745,1.111047348,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4740,7794,0.7266522305,0.5491491846,0.9615300884,1,1
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4647,17285,0.7560077401,0.6470058595,0.883373303,1,1
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1074,417,1.7351135605,0.6682922849,4.5049436241,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4740,1751,0.8499298734,0.5771973608,1.2515316923,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4647,3983,1.2287318413,1.0183955129,1.4825103987,1,1
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1074,1880,0.6377915014,0.3640465399,1.1173791113,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4740,7794,0.7294872202,0.5508841165,0.965995549,1,1
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4647,17285,0.7581261693,0.64675049,0.8886816438,1,1
Cancer,Solid Cancer,"c Weighted, covariates (age)",TNF vs DMARD,MPCD,1074,417,1.521773664,0.5805411068,3.9890286103,1,0
Cancer,Solid Cancer,"c Weighted, covariates (age)",TNF vs DMARD,Marketscan,4740,1751,0.8179322875,0.5560413239,1.2031717757,1,0
Cancer,Solid Cancer,"c Weighted, covariates (age)",TNF vs DMARD,Medicare,4647,3983,1.1926897174,0.9845582838,1.4448192509,1,0
Cancer,Solid Cancer,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,MPCD,1074,1880,0.7427650788,0.4211166162,1.310088325,1,0
Cancer,Solid Cancer,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Marketscan,4740,7794,0.7748298391,0.584537218,1.0270710933,1,0
Cancer,Solid Cancer,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Medicare,4647,17285,0.8109208875,0.6917915055,0.9505648458,1,1
Cancer,Solid Cancer,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,MPCD,1074,417,1.4983351373,0.5714790286,3.9284174422,1,0
Cancer,Solid Cancer,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Marketscan,4740,1751,0.8065532602,0.5482164552,1.1866264782,1,0
Cancer,Solid Cancer,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Medicare,4647,3983,1.1786189437,0.978274913,1.4199920656,1,0
Cancer,Solid Cancer,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,MPCD,1074,1880,0.7487331435,0.4239709552,1.3222635023,1,0
Cancer,Solid Cancer,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Marketscan,4740,7794,0.7776022008,0.5862847406,1.0313507087,1,0
Cancer,Solid Cancer,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Medicare,4647,17285,0.8149826878,0.692306696,0.9593967315,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1077,420,19198.566195,9880.5270098,37304.178569,0,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4771,1785,0.6203948185,0.3352768116,1.1479759934,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4735,4105,0.6701897,0.5446640521,0.824644535,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1077,1895,0.4794263681,0.2275522584,1.010096072,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4771,7863,0.5661038679,0.3816385435,0.8397306685,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4735,17568,0.5145721792,0.4386811081,0.603592274,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs DMARD,MPCD,1077,420,18992.145494,9010.2209682,40032.491073,0,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4771,1785,1.1264839904,0.5656889209,2.2432226153,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs DMARD,Medicare,4735,4105,1.1372717104,0.8962139819,1.4431675575,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1077,1895,0.5440378065,0.2398151142,1.2341888285,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4771,7863,0.9927470884,0.6133419657,1.6068471368,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4735,17568,0.8494786254,0.697732442,1.0342272935,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1077,420,18865.418574,8945.5065704,39785.786885,0,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4771,1785,1.1267726733,0.5667786331,2.2400573752,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4735,4105,1.1500311912,0.9139052721,1.4471650194,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1077,1895,0.5461339876,0.2406296676,1.2395077276,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4771,7863,0.9960514086,0.6146509461,1.6141167842,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4735,17568,0.8490641597,0.6936378869,1.0393174319,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (age)",TNF vs DMARD,MPCD,1077,420,18770.816934,8637.9755401,40790.063219,0,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (age)",TNF vs DMARD,Marketscan,4771,1785,1.0315051876,0.519487967,2.0481763191,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (age)",TNF vs DMARD,Medicare,4735,4105,1.0651062847,0.8406952699,1.3494204598,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,MPCD,1077,1895,0.6316790964,0.2748411981,1.4518146609,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Marketscan,4771,7863,1.0557005234,0.6504067954,1.71354851,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Medicare,4735,17568,0.9045584273,0.7410698899,1.1041144156,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,MPCD,1077,420,18473.000206,8490.8656105,40190.453162,0,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Marketscan,4771,1785,1.0263451696,0.5181457547,2.03298859,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Medicare,4735,4105,1.0697389448,0.8509850891,1.3447255712,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,MPCD,1077,1895,0.6329292211,0.2750964645,1.4562142758,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Marketscan,4771,7863,1.0586400094,0.6522490161,1.7182374243,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Medicare,4735,17568,0.9063258316,0.737761202,1.1134043247,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1082,421,6517.4188723,2093.9391999,20285.569304,0,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4773,1785,0.8771640443,0.4544895642,1.6929250336,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4764,4126,0.7758891079,0.633906183,0.9496735068,1,1
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1082,1899,0.3679026688,0.1050685168,1.2882296026,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4773,7849,0.60238482,0.4173671198,0.8694203596,1,1
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4764,17524,0.5374626199,0.4626929409,0.6243148365,1,1
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs DMARD,MPCD,1082,421,13615.292745,2941.978584,63010.722629,0,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4773,1785,1.3375796374,0.6439653608,2.7782849752,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs DMARD,Medicare,4764,4126,1.2242556996,0.9603250916,1.5607235832,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1082,1899,0.8413248361,0.1653216309,4.2815176458,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4773,7849,0.9776725854,0.6250288039,1.529279416,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4764,17524,0.8472317812,0.6911023129,1.0386330326,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1082,421,13745.191566,2973.8893351,63529.697943,0,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4773,1785,1.3504735,0.6519149142,2.7975716378,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4764,4126,1.2456634352,0.9865164784,1.5728854284,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1082,1899,0.8382664446,0.1645758495,4.2697068503,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4773,7849,0.974530776,0.6218779599,1.5271649658,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4764,17524,0.8425473978,0.6837166404,1.0382753258,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (age)",TNF vs DMARD,MPCD,1082,421,13434.552067,2949.0716375,61201.358067,0,0
Cardiac disease,Conduction Block,"c Weighted, covariates (age)",TNF vs DMARD,Marketscan,4773,1785,1.2460030457,0.6017147342,2.5801654864,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (age)",TNF vs DMARD,Medicare,4764,4126,1.1576085302,0.9111876291,1.4706713154,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,MPCD,1082,1899,0.9765121488,0.1934534324,4.9292274888,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Marketscan,4773,7849,1.0190997948,0.6535708962,1.5890615657,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Medicare,4764,17524,0.9004402951,0.7324519102,1.1069569396,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,MPCD,1082,421,13530.79223,2972.5969717,61590.03057,0,0
Cardiac disease,Conduction Block,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Marketscan,4773,1785,1.2521494492,0.6058334275,2.5879691876,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Medicare,4764,4126,1.1724157206,0.9318499418,1.4750858054,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,MPCD,1082,1899,0.9712952257,0.192197685,4.9085628456,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Marketscan,4773,7849,1.0167667907,0.6510285376,1.587971413,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Medicare,4764,17524,0.8951692218,0.7240098489,1.1067914849,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1080,421,26365.910039,10888.52466,63843.47135,0,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4785,1791,0.766932229,0.2761723531,2.1297752553,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4820,4186,0.5714148071,0.4310743887,0.7574444001,1,1
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1080,1900,1.3409681819,0.4093374073,4.3929424301,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4785,7869,0.5586525027,0.2999212516,1.0405818765,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4820,17702,0.5262448977,0.4201607423,0.6591136785,1,1
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs DMARD,MPCD,1080,421,51862.401265,18624.812248,144415.34385,0,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4785,1791,1.3837430664,0.466606717,4.1035518862,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs DMARD,Medicare,4820,4186,0.7881332599,0.5722911009,1.0853812586,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1080,1900,2.9221587523,0.7989089988,10.688340958,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4785,7869,0.8976528982,0.4373983739,1.8422124402,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4820,17702,0.7002159028,0.53473764,0.9169025591,1,1
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1080,421,55054.528656,19805.882814,153035.3963,0,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4785,1791,1.4638388427,0.4926490293,4.3495958174,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4820,4186,0.8731820183,0.635708292,1.1993658832,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1080,1900,2.8913696877,0.7891525042,10.593666783,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4785,7869,0.8890468859,0.4343910735,1.819568618,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4820,17702,0.681712923,0.516794834,0.8992592009,1,1
Cardiac disease,Myocardial infarction,"c Weighted, covariates (age)",TNF vs DMARD,MPCD,1080,421,337797.41593,123114.51083,926837.08399,0,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (age)",TNF vs DMARD,Marketscan,4785,1791,1.3229167066,0.4477206971,3.9089294375,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (age)",TNF vs DMARD,Medicare,4820,4186,0.7553641072,0.5501346007,1.0371551502,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,MPCD,1080,1900,3.3651468256,0.9210735265,12.294581086,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Marketscan,4785,7869,0.9338618609,0.4547617899,1.9177028384,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Medicare,4820,17702,0.7366325859,0.5611680732,0.9669608669,1,1
Cardiac disease,Myocardial infarction,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,MPCD,1080,421,354139.40775,128944.30171,972627.08363,0,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Marketscan,4785,1791,1.3874691847,0.4715165905,4.0827211118,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Medicare,4820,4186,0.8325700923,0.6066107508,1.1426981101,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,MPCD,1080,1900,3.2798933157,0.8959360049,12.007219381,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Marketscan,4785,7869,0.9253384977,0.4547932581,1.882726536,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Medicare,4820,17702,0.7151454569,0.5399210323,0.9472367142,1,1
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1083,421,1.229466853,0.6056789565,2.4956930178,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4795,1796,0.8611863301,0.6978113033,1.0628115246,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4864,4229,0.7888738659,0.7267951513,0.8562549917,1,1
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1083,1901,0.5795927292,0.4032271981,0.8330978995,1,1
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4795,7897,0.7346100488,0.6463210579,0.8349595254,1,1
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4864,17850,0.6678935752,0.6281114435,0.7101953522,1,1
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs DMARD,MPCD,1083,421,1.5667046581,0.7442343443,3.2981056363,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4795,1796,0.9690306471,0.7746300311,1.212217907,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs DMARD,Medicare,4864,4229,0.8843000668,0.8038088167,0.9728514938,1,1
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1083,1901,0.8048214709,0.5349778793,1.2107745482,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4795,7897,0.8031415735,0.6939423778,0.9295244212,1,1
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4864,17850,0.7564011952,0.7000614956,0.8172750134,1,1
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1083,421,1.6999615624,0.8069625793,3.5811689263,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4795,1796,1.0515950896,0.8398551845,1.3167177543,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4864,4229,0.9742773412,0.8875605384,1.0694665844,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1083,1901,0.7831444217,0.5209567173,1.17728626,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4795,7897,0.7828429485,0.6764423925,0.905979709,1,1
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4864,17850,0.7288280246,0.673592911,0.7885924582,1,1
Infection,Hospitalized infection,"c Weighted, covariates (age)",TNF vs DMARD,MPCD,1083,421,1.5159665721,0.721160062,3.1867469776,1,0
Infection,Hospitalized infection,"c Weighted, covariates (age)",TNF vs DMARD,Marketscan,4795,1796,0.9546910392,0.76333628,1.1940150157,1,0
Infection,Hospitalized infection,"c Weighted, covariates (age)",TNF vs DMARD,Medicare,4864,4229,0.8680610246,0.7892129684,0.9547865691,1,1
Infection,Hospitalized infection,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,MPCD,1083,1901,0.8401471221,0.558936432,1.2628398264,1,0
Infection,Hospitalized infection,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Marketscan,4795,7897,0.8098495584,0.6993685484,0.9377835317,1,1
Infection,Hospitalized infection,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Medicare,4864,17850,0.7720608272,0.7127429792,0.8363153877,1,1
Infection,Hospitalized infection,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,MPCD,1083,421,1.6452015211,0.7819639361,3.4613975404,1,0
Infection,Hospitalized infection,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Marketscan,4795,1796,1.0318116718,0.8244916023,1.2912627894,1,0
Infection,Hospitalized infection,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Medicare,4864,4229,0.9522000824,0.8679042515,1.0446832072,1,0
Infection,Hospitalized infection,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,MPCD,1083,1901,0.8140105217,0.5421707621,1.2221484,1,0
Infection,Hospitalized infection,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Marketscan,4795,7897,0.7900401383,0.6824913343,0.9145367694,1,1
Infection,Hospitalized infection,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Medicare,4864,17850,0.74268392,0.6847873412,0.8054754692,1,1
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1083,421,0.899512545,0.1821455236,4.4421778957,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4795,1796,0.6708775602,0.3810974212,1.1810016962,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4864,4229,0.8407586615,0.6653922499,1.062343493,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1083,1901,1.9438770247,0.5929650659,6.372479771,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4795,7897,1.3273244035,0.8655512314,2.0354544112,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4864,17850,0.8179570169,0.6856404139,0.9758084092,1,1
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs DMARD,MPCD,1083,421,1.2576402687,0.1982663654,7.977445101,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4795,1796,0.7771737627,0.4090553002,1.4765706667,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs DMARD,Medicare,4864,4229,0.9224757971,0.6834810485,1.2450405145,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1083,1901,2.4066786177,0.5345485915,10.835501321,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4795,7897,1.5086197408,0.9036742541,2.5185331019,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4864,17850,0.9327414488,0.7193163405,1.2094909587,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1083,421,1.3354607545,0.2106018466,8.4683750665,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4795,1796,0.8232164554,0.4340554606,1.5612874253,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4864,4229,0.9958139256,0.7485194407,1.3248091105,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1083,1901,2.3510637684,0.5213199856,10.602894568,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4795,7897,1.4789117757,0.883644055,2.4751822049,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4864,17850,0.9062396024,0.6928378686,1.1853714326,1,0
Infection,Opportunistic infection,"c Weighted, covariates (age)",TNF vs DMARD,MPCD,1083,421,1.2116123446,0.1914489366,7.6678643397,1,0
Infection,Opportunistic infection,"c Weighted, covariates (age)",TNF vs DMARD,Marketscan,4795,1796,0.7644138142,0.403251064,1.4490438624,1,0
Infection,Opportunistic infection,"c Weighted, covariates (age)",TNF vs DMARD,Medicare,4864,4229,0.9019924736,0.6740134322,1.2070833957,1,0
Infection,Opportunistic infection,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,MPCD,1083,1901,2.5029121781,0.5541959278,11.303889215,1,0
Infection,Opportunistic infection,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Marketscan,4795,7897,1.5266531454,0.913951294,2.5501028795,1,0
Infection,Opportunistic infection,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Medicare,4864,17850,0.9519012371,0.7290113321,1.2429381071,1,0
Infection,Opportunistic infection,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,MPCD,1083,421,1.286986462,0.2033945434,8.1434542249,1,0
Infection,Opportunistic infection,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Marketscan,4795,1796,0.8076920343,0.4267133762,1.5288164343,1,0
Infection,Opportunistic infection,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Medicare,4864,4229,0.9725157769,0.7365735513,1.2840359726,1,0
Infection,Opportunistic infection,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,MPCD,1083,1901,2.4399156075,0.5393289726,11.038139009,1,0
Infection,Opportunistic infection,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Marketscan,4795,7897,1.4967024533,0.8936036207,2.5068365681,1,0
Infection,Opportunistic infection,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Medicare,4864,17850,0.9244376596,0.7016962432,1.2178845118,1,0
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1042,407,1.5590108302,0.5951500929,4.0838685867,1,0
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4596,1734,2.3433592304,1.3435532113,4.0871715659,1,1
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4515,3966,1.4778828422,1.1033945096,1.9794712374,1,1
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1042,1874,0.9778151151,0.5907596581,1.6184625781,1,0
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4596,7786,1.504119615,1.1538284488,1.9607557938,1,1
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4515,17493,1.0415625333,0.8610063542,1.2599820029,1,0
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs DMARD,MPCD,1042,407,1.6046014725,0.590766712,4.3583123987,1,0
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4596,1734,2.5978645107,1.468482364,4.5958332095,1,1
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs DMARD,Medicare,4515,3966,1.5060405917,1.0828950442,2.0945319456,1,1
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1042,1874,1.0634015904,0.6143715132,1.8406174735,1,0
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4596,7786,1.504901194,1.1343362045,1.9965223666,1,1
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4515,17493,1.0758934394,0.8442280385,1.3711303584,1,0
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1042,407,1.6880530039,0.6204785283,4.5924601964,1,0
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4596,1734,2.7386907369,1.5433896275,4.8597106128,1,1
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4515,3966,1.6018599867,1.1554323208,2.2207751773,1,1
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1042,1874,1.0465315299,0.6037648514,1.8139980168,1,0
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4596,7786,1.4857091662,1.1189201826,1.9727338563,1,1
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4515,17493,1.0613784423,0.8303994889,1.3566051192,1,0
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (age)",TNF vs DMARD,MPCD,1042,407,1.6053758924,0.5906858804,4.3631172532,1,0
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (age)",TNF vs DMARD,Marketscan,4596,1734,2.5685763741,1.4508518485,4.547386831,1,1
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (age)",TNF vs DMARD,Medicare,4515,3966,1.5039755108,1.0869163574,2.081063848,1,1
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,MPCD,1042,1874,1.0602361399,0.6121411393,1.8363423078,1,0
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Marketscan,4596,7786,1.5069116975,1.1355110878,1.9997892476,1,1
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Medicare,4515,17493,1.0759855605,0.8371478922,1.3829634372,1,0
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,MPCD,1042,407,1.6909405633,0.6212109593,4.602752005,1,0
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Marketscan,4596,1734,2.7057681831,1.5235835474,4.8052379358,1,1
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Medicare,4515,3966,1.6004030148,1.1599052534,2.2081888173,1,1
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,MPCD,1042,1874,1.042283961,0.6009395798,1.8077621975,1,0
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Marketscan,4596,7786,1.4878106149,1.1201136071,1.9762106377,1,1
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Medicare,4515,17493,1.0609823869,0.8221885936,1.3691306764,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1064,414,5.7001289314,0.7602901446,42.735618848,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4682,1773,0.980012121,0.6155199867,1.5603453633,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4695,4072,1.3759988981,1.0386957647,1.8228369,1,1
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1064,1884,1.0537431397,0.5824414878,1.9064139964,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4682,7843,1.2620618031,0.951753078,1.6735433084,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4695,17670,1.2558104771,1.0370577782,1.5207059699,1,1
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs DMARD,MPCD,1064,414,5.5556011702,0.720866057,42.816143252,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4682,1773,0.8907438342,0.5523613508,1.4364230535,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs DMARD,Medicare,4695,4072,1.4422463775,1.0539215013,1.9736523173,1,1
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1064,1884,0.9519322295,0.4774814232,1.8978224608,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4682,7843,1.1281664489,0.8370566983,1.5205177128,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4695,17670,1.2927905107,1.0249289484,1.6306567467,1,1
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1064,414,5.7085758358,0.7401913543,44.02623441,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4682,1773,0.9150782144,0.5663326112,1.4785801167,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4695,4072,1.4963993348,1.0988244633,2.0378240966,1,1
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1064,1884,0.9434979632,0.4726864866,1.8832533438,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4682,7843,1.1192502447,0.8298299156,1.5096118934,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4695,17670,1.2798878929,1.0113465169,1.6197346716,1,1
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (age)",TNF vs DMARD,MPCD,1064,414,5.4955361714,0.7128443647,42.366776408,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (age)",TNF vs DMARD,Marketscan,4682,1773,0.8713987221,0.5408873039,1.403870506,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (age)",TNF vs DMARD,Medicare,4695,4072,1.4147359582,1.039456583,1.9255040222,1,1
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,MPCD,1064,1884,0.9611146534,0.4821311372,1.9159546141,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Marketscan,4682,7843,1.1305095681,0.8387618379,1.5237363286,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Medicare,4695,17670,1.3069002441,1.0280422165,1.6613989392,1,1
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,MPCD,1064,414,5.6458651643,0.7317887913,43.558734202,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Marketscan,4682,1773,0.8943978647,0.5538144642,1.4444323724,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Medicare,4695,4072,1.4676382656,1.0831634522,1.9885845246,1,1
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,MPCD,1064,1884,0.9521568976,0.4770050792,1.9006144736,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Marketscan,4682,7843,1.1215794601,0.8314854744,1.5128832963,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Medicare,4695,17670,1.2945438724,1.0147065614,1.6515551405,1,1
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1082,420,832032.88584,265643.86714,2606040.6761,0,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4792,1795,366468.42654,164167.39185,818062.01668,0,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4853,4219,1.7418131848,0.7699174541,3.9405694138,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1082,1900,4.8037422253,0.4989977218,46.244578602,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4792,7894,1.6521680622,0.5050692455,5.4045248841,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4853,17833,1.1785658981,0.7030203347,1.9757857742,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs DMARD,MPCD,1082,420,732710.21617,217046.30133,2473501.0806,0,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4792,1795,219796.61958,96157.541934,502410.45066,0,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs DMARD,Medicare,4853,4219,2.1063498119,0.9002851216,4.9281160196,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1082,1900,5.7087604488,0.5715954104,57.015758469,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4792,7894,1.2549090632,0.3765446993,4.1822305818,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4853,17833,1.3268779577,0.7538894493,2.3353624546,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1082,420,708442.01764,206729.68091,2427760.2043,0,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4792,1795,214237.53547,92610.512842,495599.47566,0,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4853,4219,2.0685224894,0.9096058486,4.7039993157,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1082,1900,5.7771811837,0.5792988799,57.61416703,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4792,7894,1.2697259979,0.3810801471,4.2306168974,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4853,17833,1.3462993105,0.7510497236,2.413318022,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (age)",TNF vs DMARD,MPCD,1082,420,700115.49549,205447.19302,2385828.2015,0,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (age)",TNF vs DMARD,Marketscan,4792,1795,224678.82732,97823.794202,516035.75447,0,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (age)",TNF vs DMARD,Medicare,4853,4219,2.1751786657,0.9230342013,5.1259229843,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,MPCD,1082,1900,5.6315475474,0.5627732958,56.353647225,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Marketscan,4792,7894,1.2454270843,0.3734013265,4.1539451312,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Medicare,4853,17833,1.2750837535,0.7291135219,2.2298840024,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,MPCD,1082,420,680512.32065,196251.82738,2359708.0585,0,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Marketscan,4792,1795,220232.13004,94682.557986,512261.09785,0,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Medicare,4853,4219,2.1280233467,0.9295113095,4.8718970039,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,MPCD,1082,1900,5.6695200012,0.5670724008,56.683162501,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Marketscan,4792,7894,1.2591088986,0.3776080391,4.1984149026,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Medicare,4853,17833,1.2882133284,0.7238143559,2.2927060869,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1083,421,799328.50832,196806.99043,3246460.2137,0,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4793,1796,0.2871815326,0.0402924494,2.046865702,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4858,4222,1.4606750235,0.6140650295,3.4745042005,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1083,1901,792657.12184,196807.52673,3192486.1983,0,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4793,7897,0.7038342585,0.1287383283,3.8479811712,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4858,17844,2.080796861,1.1461513796,3.777612324,1,1
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs DMARD,MPCD,1083,421,666879.65376,152754.98328,2911384.382,0,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4793,1796,0.6013626315,0.0835250632,4.3296826202,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs DMARD,Medicare,4858,4222,1.3654322499,0.5454162679,3.4183161354,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1083,1901,663111.82598,153228.2521,2869688.114,0,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4793,7897,1.2397096247,0.2215783866,6.9360553507,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4858,17844,1.8407514243,0.9335783313,3.629439215,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1083,421,630550.63035,143170.40636,2777069.0014,0,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4793,1796,0.5630236888,0.0796725407,3.9787318341,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4858,4222,1.3089763509,0.5311457938,3.2258922266,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1083,1901,700404.92295,161871.57831,3030594.1366,0,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4793,7897,1.2648215577,0.224255483,7.1337099603,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4858,17844,1.8584590059,0.9285591808,3.7196012362,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (age)",TNF vs DMARD,MPCD,1083,421,652762.66041,148945.93128,2860763.548,0,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (age)",TNF vs DMARD,Marketscan,4793,1796,0.5980923212,0.0820644557,4.3589447036,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (age)",TNF vs DMARD,Medicare,4858,4222,1.4208034799,0.5690909235,3.547205631,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,MPCD,1083,1901,629725.64097,144470.52291,2744880.9273,0,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Marketscan,4793,7897,1.2189936297,0.217298003,6.8382840544,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Medicare,4858,17844,1.7682036523,0.8974487315,3.4838136667,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,MPCD,1083,421,620181.85959,139635.86512,2754489.605,0,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Marketscan,4793,1796,0.555721818,0.0776811318,3.9755695092,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Medicare,4858,4222,1.3682713681,0.5552019111,3.372046276,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,MPCD,1083,1901,669130.36662,153412.83655,2918500.5479,0,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Marketscan,4793,7897,1.2417298031,0.2196898517,7.0184985429,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Medicare,4858,17844,1.7896398515,0.8962687127,3.5734939231,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1083,421,1.0103248009,0.8838933662,1.1548408918,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4792,1795,1.1219697548,0.1253384902,10.043332491,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4841,4188,0.5551048426,0.3674381452,0.8386211129,1,1
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1083,1901,0.9973345295,0.9153143899,1.0867043878,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4792,7892,2.7786096329,0.5090787674,15.165966421,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4841,17792,1.0048433411,0.7067086097,1.428750303,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs DMARD,MPCD,1083,421,1.0212146546,0.875010235,1.1918481967,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4792,1795,1.2991183961,0.1429212895,11.808657853,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs DMARD,Medicare,4841,4188,0.853117945,0.5302643485,1.3725422613,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1083,1901,1.0082736681,0.9078883134,1.1197586473,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4792,7892,2.2169459123,0.3839794882,12.799770116,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4841,17792,1.5482574071,1.0118473264,2.3690342764,1,1
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1083,421,1.1177772034,0.905508175,1.379806291,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4792,1795,1.5939111752,0.174848076,14.530058854,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4841,4188,1.073147217,0.6866059644,1.6773011146,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1083,1901,1.0294913509,0.9103346169,1.1642449071,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4792,7892,2.0680269533,0.3572302484,11.971929867,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4841,17792,1.4395536233,0.9228695278,2.2455120383,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (age)",TNF vs DMARD,MPCD,1083,421,0.9337449138,0.7392965451,1.179336722,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (age)",TNF vs DMARD,Marketscan,4792,1795,1.2188477705,0.1334616378,11.131212775,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (age)",TNF vs DMARD,Medicare,4841,4188,0.8076488093,0.5088724746,1.2818468904,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,MPCD,1083,1901,1.1172559267,0.9314608622,1.3401108479,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Marketscan,4792,7892,2.3344795742,0.4039090259,13.492629611,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Medicare,4841,17792,1.6470965186,1.0683378778,2.5393903914,1,1
Lung disease,Interstitial lung disease,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,MPCD,1083,421,1.1036380855,0.8322446073,1.4635324917,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Marketscan,4792,1795,1.4505752693,0.1582111683,13.299747638,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Medicare,4841,4188,1.0204933383,0.6567176724,1.5857752842,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,MPCD,1083,1901,1.2954878665,1.0524444299,1.5946578885,1,1
Lung disease,Interstitial lung disease,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Marketscan,4792,7892,2.2065926138,0.3804799611,12.797128525,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Medicare,4841,17792,1.5374269484,0.9739662481,2.4268619434,1,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1080,419,19664.206686,9740.2136126,39699.439864,0,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4769,1780,1.0597220613,0.5621344395,1.9977620449,1,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4737,4088,0.8899209991,0.7285349218,1.0870575466,1,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1080,1891,0.4929865691,0.223097773,1.0893688182,1,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4769,7853,0.8104325251,0.5631647867,1.1662676596,1,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4737,17629,0.856206523,0.7378758196,0.9935135297,1,1
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs DMARD,MPCD,1080,419,38016.577875,14700.748494,98312.014105,0,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4769,1780,1.3516064517,0.6692558539,2.7296586045,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs DMARD,Medicare,4737,4088,1.0436755381,0.8334220448,1.3069712225,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1080,1891,1.0184395957,0.3670676276,2.8256896874,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4769,7853,1.0358348314,0.6609708669,1.6232996818,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4737,17629,0.9951187796,0.8326754965,1.1892524635,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1080,419,39585.967911,15355.711692,102049.90083,0,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4769,1780,1.4103599632,0.6993011617,2.8444328921,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4737,4088,1.0987547127,0.8826780143,1.3677262822,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1080,1891,1.0039662475,0.3611942637,2.7905986538,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4769,7853,1.0240186649,0.6529171376,1.6060448801,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4737,17629,0.9786307931,0.8152250506,1.1747899903,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (age)",TNF vs DMARD,MPCD,1080,419,35924.897044,13950.673209,92511.537493,0,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (age)",TNF vs DMARD,Marketscan,4769,1780,1.3596934381,0.6752356543,2.7379570879,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (age)",TNF vs DMARD,Medicare,4737,4088,1.0366416439,0.8297214185,1.295164707,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,MPCD,1080,1891,1.0978237552,0.3937233875,3.0610754546,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Marketscan,4769,7853,1.0599746335,0.6761379735,1.6617114667,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Medicare,4737,17629,1.0230420443,0.8533330248,1.2265024253,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,MPCD,1080,419,37342.603206,14541.435554,95896.31017,0,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Marketscan,4769,1780,1.4143922952,0.703805468,2.842412649,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Medicare,4737,4088,1.0875614182,0.8753391477,1.3512360797,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,MPCD,1080,1891,1.0790723169,0.3862935279,3.0142805432,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Marketscan,4769,7853,1.04895584,0.6688120413,1.645168278,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Medicare,4737,17629,1.005343396,0.834356864,1.2113705628,1,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1083,421,1.0067197778,0.0108681491,93.25274294,1,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4795,1796,0.5722679241,0.0523639573,6.2541219863,1,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4861,4224,7.381470396,0.9415897284,57.866078574,1,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1083,1899,3.2951189E-7,2.3784145E-9,0.0000456515,0,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4795,7896,2203373.534,554904.21744,8748996.2733,0,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4861,17837,1.3330086602,0.6487806431,2.7388488036,1,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs DMARD,MPCD,1083,421,1.0224087859,0.8385627712,1.2465610939,1,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4795,1796,0.8514680506,0.0776158639,9.3408461221,1,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs DMARD,Medicare,4861,4224,15.917053751,1.8667440144,135.71898352,1,1
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1083,1899,1.7638757E-6,2.4670592E-7,0.0000126112,0,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4795,7896,575803.36759,144882.18855,2288407.7155,0,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4861,17837,2.5232400768,0.9781171103,6.5091801566,1,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1083,421,0.9464228723,0.7066086582,1.2676270561,1,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4795,1796,0.7977064975,0.0723414621,8.7962786221,1,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4861,4224,14.329097735,1.6881328766,121.62729886,1,1
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1083,1899,1.7442085E-6,2.4491832E-7,0.0000124215,0,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4795,7896,600767.00508,149908.11215,2407614.833,0,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4861,17837,2.5930199502,0.9856955214,6.8213280027,1,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (age)",TNF vs DMARD,MPCD,1083,421,0.8723520538,0.6004597127,1.267359141,1,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (age)",TNF vs DMARD,Marketscan,4795,1796,0.8020693563,0.0730310356,8.8087926874,1,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (age)",TNF vs DMARD,Medicare,4861,4224,15.700692192,1.8732211485,131.59777504,1,1
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,MPCD,1083,1899,7.833371E-7,1.0817376E-7,5.6725127E-6,0,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Marketscan,4795,7896,1554584.8159,395035.74763,6117760.1379,0,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Medicare,4861,17837,2.6504768444,1.0057825451,6.9846385156,1,1
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,MPCD,1083,421,0.7935222241,0.5790753199,1.0873844878,1,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Marketscan,4795,1796,0.7490989242,0.0679968511,8.2525762461,1,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Medicare,4861,4224,14.214380601,1.6965400995,119.09451237,1,1
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,MPCD,1083,1899,7.8456224E-7,1.1032312E-7,5.5794097E-6,0,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Marketscan,4795,7896,1616882.4996,408601.6385,6398185.3498,0,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Medicare,4861,17837,2.7392865275,1.018337473,7.3685697311,1,1
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1083,421,1.0025140728,1.0025140728,1.0025140728,1,1
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4792,1794,1.1457762054,0.3234505472,4.0587444491,1,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4846,4208,0.7084895523,0.4031306832,1.245148203,1,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1083,1899,7.0175604E-6,1.7708343E-6,0.0000278096,0,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4792,7891,0.8060772105,0.3975253036,1.6345134846,1,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4846,17805,0.585600005,0.3809569565,0.9001735236,1,1
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs DMARD,MPCD,1083,421,1.0001725425,0.860342339,1.1627291479,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4792,1794,0.7354734639,0.1978447449,2.7340691632,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs DMARD,Medicare,4846,4208,0.587394735,0.326216854,1.0576785672,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1083,1899,5.6593056E-6,1.3920847E-6,0.000023007,0,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4792,7891,0.6995534014,0.3308638884,1.479082422,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4846,17805,0.4848414544,0.3084497825,0.7621053709,1,1
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1083,421,0.989792286,0.8312179115,1.1786184536,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4792,1794,0.7717404159,0.2082379825,2.8601087199,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4846,4208,0.6373543209,0.3526781197,1.1518166499,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1083,1899,5.470572E-6,1.3425589E-6,0.0000222911,0,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4792,7891,0.6955950318,0.3282480085,1.4740453432,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4846,17805,0.477417899,0.3025306021,0.7534042794,1,1
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (age)",TNF vs DMARD,MPCD,1083,421,0.9498132535,0.8086027655,1.1156840603,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (age)",TNF vs DMARD,Marketscan,4792,1794,0.7475897048,0.2015624655,2.7727898911,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (age)",TNF vs DMARD,Medicare,4846,4208,0.5978136368,0.330196635,1.0823282447,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,MPCD,1083,1899,5.9130019E-6,1.4553835E-6,0.0000240236,0,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Marketscan,4792,7891,0.7007147941,0.3312346784,1.4823364059,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Medicare,4846,17805,0.4812194734,0.3077042528,0.7525803738,1,1
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,MPCD,1083,421,0.9419323509,0.7791455332,1.1387302063,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Marketscan,4792,1794,0.7873734774,0.2129515279,2.9112587214,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Medicare,4846,4208,0.6478526651,0.3567665398,1.1764362094,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,MPCD,1083,1899,5.6940905E-6,1.3987538E-6,0.0000231797,0,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Marketscan,4792,7891,0.6968686636,0.328725059,1.477301231,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Medicare,4846,17805,0.4733459415,0.3018249391,0.7423388569,1,1
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1079,420,2.6978697438,0.3435941481,21.183425839,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4777,1792,0.867184684,0.4099732503,1.8342886411,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4741,4088,0.8112875896,0.6586280209,0.9993312343,1,1
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1079,1892,0.8488715142,0.3775665755,1.908492156,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4777,7826,0.3972964419,0.2608542768,0.6051059032,1,1
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4741,17263,0.5866309068,0.5035622913,0.6834026828,1,1
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs DMARD,MPCD,1079,420,1.8800201886,0.234710086,15.058900833,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4777,1792,1.1038357538,0.483092427,2.5221951399,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs DMARD,Medicare,4741,4088,0.9582626533,0.7566556871,1.2135867454,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1079,1892,0.8445238147,0.3604292082,1.9788087572,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4777,7826,0.5067677598,0.2962162931,0.866979867,1,1
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4741,17263,0.6863492694,0.5695481692,0.8271035622,1,1
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1079,420,1.9403830708,0.2422585231,15.541605771,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4777,1792,1.1456999748,0.5014969125,2.6174207646,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4741,4088,1.0129153662,0.8039239957,1.2762369882,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1079,1892,0.8352076004,0.3565171324,1.9566289312,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4777,7826,0.5020308542,0.2931519464,0.859741788,1,1
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4741,17263,0.6736738525,0.5568229359,0.8150462748,1,1
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (age)",TNF vs DMARD,MPCD,1079,420,1.7405404938,0.21614554,14.015932091,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (age)",TNF vs DMARD,Marketscan,4777,1792,1.0694406199,0.469455969,2.4362311163,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (age)",TNF vs DMARD,Medicare,4741,4088,0.9217701447,0.7296405587,1.1644914603,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,MPCD,1079,1892,0.9092301117,0.3866653878,2.1380227508,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Marketscan,4777,7826,0.5177391953,0.3024269496,0.8863425519,1,1
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Medicare,4741,17263,0.709950353,0.5873276426,0.8581743257,1,1
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,MPCD,1079,420,1.7966041393,0.2231476606,14.464800686,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Marketscan,4777,1792,1.1057447433,0.4854300234,2.5187388057,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Medicare,4741,4088,0.9707821381,0.7719652685,1.2208035751,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,MPCD,1079,1892,0.8953744471,0.3808419472,2.1050606595,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Marketscan,4777,7826,0.5133531344,0.2995623353,0.8797215452,1,1
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Medicare,4741,17263,0.6963179354,0.5735145865,0.8454164524,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1073,416,1.3247452478,0.4491033434,3.9076751431,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4758,1782,1.1326856525,0.6715718265,1.9104088896,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4692,4050,0.8076295408,0.6824664747,0.9557472775,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1073,1884,0.5156962328,0.3028785305,0.8780503658,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4758,7816,1.0213211839,0.7614868572,1.3698161051,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4692,17452,0.793197445,0.6977163444,0.9017449452,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs DMARD,MPCD,1073,416,1.2342609007,0.3652814361,4.1704828675,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4758,1782,1.247425085,0.7307802676,2.1293258884,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs DMARD,Medicare,4692,4050,0.97181046,0.7968083831,1.1852480347,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1073,1884,0.615987916,0.3168074469,1.1977026311,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4758,7816,1.0503557648,0.7614876894,1.4488050797,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4692,17452,0.9364142959,0.7954779144,1.1023206524,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1073,416,1.2965026569,0.3841937433,4.3751861361,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4758,1782,1.3055954669,0.7636761808,2.2320710872,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4692,4050,1.0264837267,0.8458626862,1.2456736282,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1073,1884,0.6056245654,0.3110205959,1.1792823981,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4758,7816,1.0351536988,0.7501983794,1.4283464343,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4692,17452,0.9170808496,0.7762922441,1.0834029209,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (age)",TNF vs DMARD,MPCD,1073,416,1.1854623516,0.3578110272,3.927550803,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (age)",TNF vs DMARD,Marketscan,4758,1782,1.2326083677,0.7209517914,2.107385551,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (age)",TNF vs DMARD,Medicare,4692,4050,0.9423297452,0.7758199758,1.1445765465,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,MPCD,1073,1884,0.6558690066,0.3395937159,1.2667023377,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Marketscan,4758,7816,1.071212011,0.7750364616,1.4805692755,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Medicare,4692,17452,0.9708352479,0.8216636759,1.1470886522,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,MPCD,1073,416,1.2423049632,0.3750096693,4.1154182092,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Marketscan,4758,1782,1.283120084,0.7493921458,2.1969767887,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Medicare,4692,4050,0.989217587,0.8186755052,1.1952860789,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,MPCD,1073,1884,0.64302946,0.3322100565,1.2446549356,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Marketscan,4758,7816,1.0557279954,0.7635765045,1.4596593711,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Medicare,4692,17452,0.9500665018,0.801224713,1.126558309,1,0
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1062,416,3.1851769545,0.9792579591,10.360244853,1,0
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4664,1756,1.6364753039,1.0881288522,2.461152845,1,1
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4590,4034,1.3404318905,1.0909325408,1.6469924453,1,1
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1062,1885,1.8608445164,1.1097652517,3.1202475558,1,1
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4664,7833,2.0207181425,1.5813966468,2.5820857909,1,1
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4590,17595,1.6061197681,1.3844547537,1.8632755621,1,1
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs DMARD,MPCD,1062,416,2.412193905,0.6602253751,8.8131714638,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4664,1756,1.3499644091,0.8723090572,2.0891722845,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs DMARD,Medicare,4590,4034,1.1108548418,0.8779548888,1.4055374545,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1062,1885,1.6482992547,0.9495737291,2.8611684904,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4664,7833,1.6635064536,1.2781466556,2.1650518029,1,1
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4590,17595,1.3740813375,1.1426754398,1.6523497894,1,1
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1062,416,2.383705573,0.6511675153,8.7259455134,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4664,1756,1.3379786257,0.8647754818,2.0701174356,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4590,4034,1.1036233985,0.876471623,1.3896452251,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1062,1885,1.6553882427,0.9537826916,2.8730970464,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4664,7833,1.6699014641,1.2816808287,2.1757139823,1,1
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4590,17595,1.3786962737,1.1418028873,1.6647386657,1,1
PsO/PsA,Psoriasis,"c Weighted, covariates (age)",TNF vs DMARD,MPCD,1062,416,2.3437760754,0.6402377617,8.5800723103,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (age)",TNF vs DMARD,Marketscan,4664,1756,1.3473616075,0.8701370962,2.0863187071,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (age)",TNF vs DMARD,Medicare,4590,4034,1.1111574419,0.8821134932,1.3996734776,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,MPCD,1062,1885,1.6837310158,0.9687727889,2.9263312987,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Marketscan,4664,7833,1.6718880684,1.2840567396,2.1768584107,1,1
PsO/PsA,Psoriasis,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Medicare,4590,17595,1.3821491867,1.1437191446,1.670284513,1,1
PsO/PsA,Psoriasis,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,MPCD,1062,416,2.3152264946,0.6311502413,8.4928648847,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Marketscan,4664,1756,1.3345396218,0.8618445147,2.0664934008,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Medicare,4590,4034,1.1030594884,0.8798609381,1.382877887,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,MPCD,1062,1885,1.690500326,0.9727046349,2.9379847178,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Marketscan,4664,7833,1.6780496165,1.2874441911,2.1871631678,1,1
PsO/PsA,Psoriasis,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Medicare,4590,17595,1.3870075518,1.1425661687,1.6837448906,1,1
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1038,403,1.3104187149,0.5737537354,2.9929168254,1,0
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4550,1727,0.8117445015,0.5883053842,1.1200460739,1,0
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4405,3940,1.2447922164,0.9924315093,1.5613245322,1,0
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1038,1882,1.6826785385,1.0062183217,2.8139092707,1,1
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4550,7808,2.0097248171,1.561944258,2.5858757889,1,1
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4405,17533,1.9056103384,1.6109801746,2.2541250471,1,1
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs DMARD,MPCD,1038,403,1.290862162,0.5397966383,3.0869497936,1,0
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4550,1727,0.7693487183,0.5468026772,1.0824699203,1,0
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs DMARD,Medicare,4405,3940,1.2902240349,1.0024557311,1.6606000728,1,1
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1038,1882,1.8160910426,1.0426264996,3.1633443772,1,1
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4550,7808,2.0197703558,1.5370012488,2.6541763017,1,1
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4405,17533,1.922211533,1.5733657555,2.3484032016,1,1
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1038,403,1.3305499652,0.5564108616,3.1817553037,1,0
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4550,1727,0.7905319846,0.5625524767,1.1109022616,1,0
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4405,3940,1.3277649958,1.0369490722,1.7001412426,1,1
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1038,1882,1.7976195609,1.0315701392,3.1325413203,1,1
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4550,7808,2.0031586682,1.5222006568,2.6360812762,1,1
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4405,17533,1.9035901354,1.5517715815,2.3351731961,1,1
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (age)",TNF vs DMARD,MPCD,1038,403,1.2701928082,0.5303656384,3.0420329923,1,0
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (age)",TNF vs DMARD,Marketscan,4550,1727,0.7755787445,0.5512657428,1.0911659155,1,0
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (age)",TNF vs DMARD,Medicare,4405,3940,1.293027091,1.0087384657,1.657435614,1,1
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,MPCD,1038,1882,1.8608269118,1.0673314083,3.2442377022,1,1
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Marketscan,4550,7808,2.0366429096,1.5481358451,2.6792961061,1,1
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Medicare,4405,17533,1.9419940733,1.582033689,2.3838563027,1,1
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,MPCD,1038,403,1.3083919608,0.5463115858,3.133540579,1,0
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Marketscan,4550,1727,0.7966096596,0.5667847067,1.1196260985,1,0
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Medicare,4405,3940,1.328884225,1.0419580638,1.6948218405,1,1
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,MPCD,1038,1882,1.8404937175,1.0551547568,3.2103509959,1,1
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Marketscan,4550,7808,2.0203478345,1.5337146804,2.6613850832,1,1
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Medicare,4405,17533,1.9226007675,1.5591626923,2.3707556174,1,1
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1020,394,0.9025262855,0.4805457194,1.6950597273,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4489,1703,1.1952418209,0.8685823908,1.6447524442,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4542,3998,1.6835775127,1.3504529003,2.0988760441,1,1
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1020,1841,0.8542527992,0.5772798479,1.2641145322,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4489,7686,0.8592978032,0.7187407451,1.0273422226,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4542,17547,1.469766792,1.2694977566,1.7016291773,1,1
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs DMARD,MPCD,1020,394,0.8751286874,0.4508601747,1.6986424226,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4489,1703,1.2925347701,0.9223039445,1.8113834834,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs DMARD,Medicare,4542,3998,1.3888082673,1.090745039,1.7683219581,1,1
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1020,1841,0.8077960449,0.5238041821,1.2457602907,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4489,7686,0.8708813281,0.7172829544,1.0573711295,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4542,17547,1.2092235629,1.0170090123,1.4377666346,1,1
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1020,394,0.8711755904,0.4488713168,1.6907895001,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4489,1703,1.2867719053,0.918330781,1.803034343,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4542,3998,1.3847549686,1.0889631348,1.7608918629,1,1
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1020,1841,0.8080524378,0.5237672929,1.2466390152,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4489,7686,0.8712942818,0.7169342972,1.0588888388,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4542,17547,1.2063785351,1.0128610285,1.4368695498,1,1
Uveitis,Uveitis,"c Weighted, covariates (age)",TNF vs DMARD,MPCD,1020,394,0.882757474,0.4551774722,1.7119932455,1,0
Uveitis,Uveitis,"c Weighted, covariates (age)",TNF vs DMARD,Marketscan,4489,1703,1.2997162326,0.9272029099,1.8218906208,1,0
Uveitis,Uveitis,"c Weighted, covariates (age)",TNF vs DMARD,Medicare,4542,3998,1.4182165604,1.1168933369,1.800832851,1,1
Uveitis,Uveitis,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,MPCD,1020,1841,0.7857569092,0.5097196924,1.211281278,1,0
Uveitis,Uveitis,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Marketscan,4489,7686,0.8636553537,0.7113593917,1.0485565787,1,0
Uveitis,Uveitis,"c Weighted, covariates (age)",TNF vs NSAID or no exposure,Medicare,4542,17547,1.1671494733,0.9775765848,1.3934845763,1,0
Uveitis,Uveitis,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,MPCD,1020,394,0.8793657351,0.4534307572,1.7054072396,1,0
Uveitis,Uveitis,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Marketscan,4489,1703,1.29558947,0.9243007034,1.8160237991,1,0
Uveitis,Uveitis,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs DMARD,Medicare,4542,3998,1.420325894,1.1199220085,1.8013090465,1,1
Uveitis,Uveitis,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,MPCD,1020,1841,0.7859423748,0.5096703351,1.2119705111,1,0
Uveitis,Uveitis,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Marketscan,4489,7686,0.864084351,0.711015752,1.0501058007,1,0
Uveitis,Uveitis,"d Weighted, covariates (6-month daily steroid dose, age)",TNF vs NSAID or no exposure,Medicare,4542,17547,1.164993323,0.9742910012,1.3930226605,1,0
